Published in Connect Tissue Res on February 01, 2011
Hierarchical model of fibrillar collagen organization for interpreting the second-order susceptibility tensors in biological tissue. Biophys J (2012) 1.26
Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis. Am J Physiol Lung Cell Mol Physiol (2013) 1.02
The dentin organic matrix - limitations of restorative dentistry hidden on the nanometer scale. Acta Biomater (2012) 0.99
Type I collagen D-spacing in fibril bundles of dermis, tendon, and bone: bridging between nano- and micro-level tissue hierarchy. ACS Nano (2012) 0.99
The signaling pathway of Campylobacter jejuni-induced Cdc42 activation: Role of fibronectin, integrin beta1, tyrosine kinases and guanine exchange factor Vav2. Cell Commun Signal (2011) 0.95
Review collagen-based biomaterials for wound healing. Biopolymers (2014) 0.93
Non-enzymatic decomposition of collagen fibers by a biglycan antibody and a plausible mechanism for rheumatoid arthritis. PLoS One (2012) 0.90
Preserved Proteins from Extinct Bison latifrons Identified by Tandem Mass Spectrometry; Hydroxylysine Glycosides are a Common Feature of Ancient Collagen. Mol Cell Proteomics (2015) 0.89
Differential effects of collagen prolyl 3-hydroxylation on skeletal tissues. PLoS Genet (2014) 0.87
Water in the formation of biogenic minerals: peeling away the hydration layers. J Struct Biol (2013) 0.85
Variation in the helical structure of native collagen. PLoS One (2014) 0.84
Reduction of fibroblast size/mechanical force down-regulates TGF-β type II receptor: implications for human skin aging. Aging Cell (2015) 0.82
X-ray micro-diffraction studies on biological samples at the BioCAT Beamline 18-ID at the Advanced Photon Source. J Synchrotron Radiat (2014) 0.82
Demineralization-remineralization dynamics in teeth and bone. Int J Nanomedicine (2016) 0.81
Biomineralization mechanisms: a new paradigm for crystal nucleation in organic matrices. Calcif Tissue Int (2012) 0.81
Mathematical modeling of collagen turnover in biological tissue. J Math Biol (2012) 0.80
Hyaluronan in aged collagen matrix increases prostate epithelial cell proliferation. In Vitro Cell Dev Biol Anim (2014) 0.79
Decreased Mechanical Strength and Collagen Content in SPARC-Null Periodontal Ligament Is Reversed by Inhibition of Transglutaminase Activity. J Bone Miner Res (2015) 0.79
Measurement of Elastic Modulus of Collagen Type I Single Fiber. PLoS One (2016) 0.79
The effect of cross-link distributions in axially-ordered, cross-linked networks. J Phys Condens Matter (2013) 0.77
Nanomechanics of Type I Collagen. Biophys J (2016) 0.77
Collagen Fibril Ultrastructure in Mice Lacking Discoidin Domain Receptor 1. Microsc Microanal (2016) 0.76
Stringent requirement for spatial arrangement of extracellular matrix in supporting cell morphogenesis and differentiation. BMC Cell Biol (2014) 0.76
Circular Dichroism Spectroscopy of Collagen Fibrillogenesis: A New Use for an Old Technique. Biophys J (2016) 0.75
Connective tissue studies, and with a focus on collagen structure. Connect Tissue Res (2011) 0.75
Targeting collagen for diagnostic imaging and therapeutic delivery. J Control Release (2016) 0.75
Thermal Destabilization of Collagen Matrix Hierarchical Structure by Freeze/Thaw. PLoS One (2016) 0.75
Supramolecular Organization of Collagen Fibrils in Healthy and Osteoarthritic Human Knee and Hip Joint Cartilage. PLoS One (2016) 0.75
Homeostatic maintenance via degradation and repair of elastic fibers under tension. Sci Rep (2016) 0.75
Fell Muir Lecture: Collagen fibril formation in vitro and in vivo. Int J Exp Pathol (2017) 0.75
Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J Clin Invest (2001) 2.18
Decorin binds near the C terminus of type I collagen. J Biol Chem (2000) 1.40
Collagen fibril surface displays a constellation of sites capable of promoting fibril assembly, stability, and hemostasis. Connect Tissue Res (2010) 1.14
Defining the domains of type I collagen involved in heparin- binding and endothelial tube formation. Proc Natl Acad Sci U S A (1998) 1.12
Design of peptides with high affinities for heparin and endothelial cell proteoglycans. J Biol Chem (2000) 1.06
Type I collagen and collagen mimetics as angiogenesis promoting superpolymers. Curr Pharm Des (2007) 0.98
Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells. Blood (2001) 0.95
Regulation of chondrogenesis by heparan sulfate and structurally related glycosaminoglycans. Dev Biol (1987) 0.91
Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque. J Biol Chem (2000) 0.90
Chondrogenesis of limb bud mesenchyme in vitro: stimulation by cations. Dev Biol (1986) 0.85
Novel design of peptides to reverse the anticoagulant activities of heparin and other glycosaminoglycans. Thromb Haemost (2001) 0.81
Myofibroblast involvement in glycosaminoglycan synthesis and lipid retention during coronary repair. J Vasc Res (2000) 0.77
Decreased serglycin proteoglycan size is associated with the platelet alpha granule storage defect in Wistar Furth hereditary macrothrombocytopenic rats. Serglycin binding affinity to type I collagen is unaltered. J Cell Physiol (1997) 0.77
Chondrogenic potential of chick embryonic calvaria: II. Matrix calcium may repress cartilage differentiation. Dev Dyn (1995) 0.76
Cisplatin-induced peptic ulcers, vagotomy, adrenal and calcium modulation. Anticancer Drugs (1994) 0.75
Insulin-like growth factor (IGF) binding protein-3 regulation of IGF-I is altered in an acidic extracellular environment. J Cell Physiol (2001) 0.75